Kuros Biosciences AG banner

Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 23.22 CHF 4.31% Market Closed
Market Cap: CHf909.8m

Wall Street
Price Targets

KURN Price Targets Summary
Kuros Biosciences AG

Wall Street analysts forecast KURN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KURN is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.

Lowest
Price Target
38.38 CHF
65% Upside
Average
Price Target
38.76 CHF
67% Upside
Highest
Price Target
39.9 CHF
72% Upside
Kuros Biosciences AG Competitors:
Price Targets
VRNS
Varonis Systems Inc
62% Upside
STG
Strip Tinning Holdings PLC
137% Upside
VNOM
Viper Energy Partners LP
19% Upside
KRNY
Kearny Financial Corp
15% Upside

Revenue
Forecast

37% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
37% / Year
Past Growth
42% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 4 years is 42%.

Operating Income
Forecast

N/A
Past Growth
371% / Year
Estimated Growth
Estimates Accuracy
33%
Average Beat
N/A
Past Growth
371% / Year
Estimated Growth
Estimates Accuracy
33%
Average Beat

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 4 years is 371%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KURN's stock price target?
Price Target
38.76 CHF

According to Wall Street analysts, the average 1-year price target for KURN is 38.76 CHF with a low forecast of 38.38 CHF and a high forecast of 39.9 CHF.

What is Kuros Biosciences AG's Revenue forecast?
Projected CAGR
42%

For the last 13 years the compound annual growth rate for Kuros Biosciences AG's revenue is 37%. The projected CAGR for the next 4 years is 42%.

What is Kuros Biosciences AG's Operating Income forecast?
Projected CAGR
371%

The compound annual growth rate of Kuros Biosciences AG's operating income for the next 4 years is 371%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett